EUVIMEDOpdag EUVIMED
Crossref

2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors

Zheng Ma, Ge Cui, Lijie Dou, Fangfang Chen, Hexin Xie iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202400901 ↗

At a glance

Journal article in ChemMedChem, 2025. Written by Zheng Ma and 4 co-authors. Institution: State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic C…. Major MEDLINE topics: Boronic Acids, Klebsiella pneumoniae, Anti-Bacterial Agents, beta-Lactamase Inhibitors. Cited 2 times so far (Crossref); 36 references. Funded by: NSFC-BRICS, Fundamental Research Funds for the Central Universities, Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The expression of Klebsiella pneumoniae carbapenemase (KPC), a type of carbapenem‐hydrolyzing β‐lactamase, in Gram‐negative bacteria has caused significant bacterial resistance to carbapenems, the antibiotic of last resort. Herein, we describe the discovery of 2‐carboxyquinoline boronic acids as inhibitor of KPC. We have identified fluoro‐substituted carboxyquinoline boronic acids 1 e as the most potent inhibitor, with an IC 50 of 8.3 nM for KPC‐2, while this compound is significantly less efficient at reducing the activity of other β‐lactamases. This compound proved to have low cytotoxicity towards mammalian cells, as well as low haemolysis and antibacterial activity. However, 1 e potentiated the efficacy of β‐lactam antibiotics (e. g., meropenem and ceftazidime) against KPC‐2‐expressing resistant Klebsiella pneumonia by up to 256‐fold.

Subjects

MeSH terms (MEDLINE)

Boronic AcidsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesQuinolinesBacterial ProteinsStructure-Activity RelationshipMicrobial Sensitivity TestsHumansMolecular StructureDose-Response Relationship, Drug

Author keywords

antibiotic resistancecarbapenemaseinhibitorβ-lactamase

Substances

Boronic AcidsAnti-Bacterial Agentsbeta-Lactamase Inhibitorsbeta-LactamasesQuinolinesBacterial Proteinscarbapenemase

Authors and institutions

  • State Key Laboratory of Bioreactor Engineering, Shanghai Key Laboratory of New Drug Design, Frontiers Science Center for Materiobiology and Dynamic Chemistry, Shanghai Frontier Science Research Base of Optogenetic Techn…

ORCID profiles: Hexin Xie

Funding

  • NSFC-BRICS
  • Fundamental Research Funds for the Central Universities
  • Shanghai Frontier Science Research Base of Optogenetic Techniques for Cell Metabolism
  • Shanghai Municipal Education Commission
  • Research Program of State Key Laboratory of Bioreactor Engineering

Cite

APA

Ma, Z., Cui, G., Dou, L., Chen, F., & Xie, H. (2025). 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202400901

Vancouver

Ma Z, Cui G, Dou L, Chen F, Xie H. 2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors. ChemMedChem. 2025. doi:10.1002/cmdc.202400901

BibTeX
@article{Ma2025,
  author = {Ma, Zheng and Cui, Ge and Dou, Lijie and Chen, Fangfang and Xie, Hexin},
  title = {2‐Carboxyquinoline Boronic Acids as Highly Potent KPC Inhibitors},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202400901}
}
Start for free →